CTi Biopharma Corp
Biotechnology
Healthcare
CTIC
128 M shares
NASDAQ US
traded
23 Jun 2023
listed
yes
open
9.10
52 week high
9.10
high
9.10
52 week low
4.08
low
9.09
growth
49.51 %
previous Close
9.09
P/E ratio
market cap
1.18 B
div yield
0
usd
Mar 2023
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
28.57 %
eps surprise
16.67 %
net profit margin
0.00 %
82.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top